Skip to content

Amoxicillin-clavulanate in Treating Acute Otitis Media Evaluated by Daily Tympanometry

Oral Amoxicillin-clavulanate in Treating Acute Otitis Media in Children: Randomized Double-blind Placebo-controlled Study Including Daily Monitoring With Tympanometry

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01244581
Enrollment
84
Registered
2010-11-19
Start date
1999-09-30
Completion date
2012-06-30
Last updated
2012-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Otitis Media, Suppurative

Keywords

middle ear effusion, amoxicillin-clavulanate, tympanometry

Brief summary

The purpose of the study is to assess the efficacy of amoxicillin-clavulanate in treating acute otitis media in children. The primary end point is time to disappearance of middle ear effusion which monitored by daily tympanometry performed by families and study physicians.

Interventions

DRUGPlacebo

Placebo mixture in two daily doses for 7 days

Amoxicillin-clavulanate 40 mg/kg/day in two daily doses for 7 days

Sponsors

University of Oulu
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 16 Years
Healthy volunteers
No

Inclusion criteria

* Children with acute otitis media

Exclusion criteria

* Amoxicillin allergy * Tympanic membrane perforation * Tympanostomy tubes (current) * Complication of acute otitis media such as mastoiditis

Design outcomes

Primary

MeasureTime frameDescription
Time (days) to disappearance of middle ear effusionWithin 60 daysDisappearance of middle ear effusion is defined as the first day of receiving a normal tympanogram (A-curve) in tympanometry.

Secondary

MeasureTime frame
Time (days) to disappearance of painWithin 60 days

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026